loading

Finanzdaten der Solid Biosciences Inc-Aktie (SLDB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
4.10%
41.69
40.05 39.90 35.18 27.79
Depreciation and Amortization
5.16%
0.386
0.407 - - -
Operating Income/Loss
4.10%
-41.69
-40.05 -39.90 -35.18 -27.79
Nonoperating Income/Loss
187.40%
2.213
0.77 -2.701 2.457 2.716
Income/Loss From Continuing Operations Before Tax
0.50%
-39.48
-39.28 -42.60 -32.73 -25.07
Income/Loss From Continuing Operations After Tax
0.50%
-39.48
-39.28 -42.60 -32.73 -25.07
Net Income/Loss
0.50%
-39.48
-39.28 -42.60 -32.73 -25.07
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
41.90%
94.14
66.34 0.6344 41.44 40.93
Diluted Average Shares
41.90%
94.14
66.34 0.6344 41.44 40.93
Basic Earnings Per Share
28.81%
-0.42
-0.59 -1.02 -0.79 -0.61
Diluted Earnings Per Share
0.00%
-0.42
-0.42 -1.02 -0.79 -0.61
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):